Testing effectiveness (Phase 2)UnknownNCT02753647What this trial is testingChidamide Plus R-CHOP in Elderly DLBCLWho this might be right forDiffuse Large B-cell Lymphoma Ruijin Hospital 49
Testing effectiveness (Phase 2)Ended earlyNCT00978432What this trial is testingEpigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Who this might be right forDiffuse Large B-cell Lymphoma Anne Beaven, MD 50
Testing effectiveness (Phase 2)Study completedNCT00001337What this trial is testingDose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell LymphomaBurkitt Lymphoma+2 more National Cancer Institute (NCI) 348
Early research (Phase 1)Study completedNCT02112526What this trial is testingAcalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell LymphomaWho this might be right forActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL) Acerta Pharma BV 21
Testing effectiveness (Phase 2)WithdrawnNCT01415765What this trial is testingMLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell LymphomaWho this might be right forLymphoma, Diffuse Large-Cell B-cellDiffuse, Large B-cell LymphomaLymphoma, Diffuse Large-Cell+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT02388581What this trial is testingFirst-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCLWho this might be right forGastric Diffuse Large B-cell Lymphoma National Health Research Institutes, Taiwan 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05583149What this trial is testingAcalabrutinib + Liso-Cel In R/R Aggressive B-Cell LymphomasWho this might be right forRefractory Aggressive B-cell LymphomasRefractory B-Cell Non-Hodgkin LymphomaAggressive B-cell NHL+10 more Patrick C. Johnson, MD 28
Early research (Phase 1)Ended earlyNCT02698189What this trial is testingA Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Hematologic Malignancies (MK-8628-005)Who this might be right forAML Including AML de Novo and AML Secondary to MDSDLBCL Merck Sharp & Dohme LLC 9
Testing effectiveness (Phase 2)UnknownNCT03201471What this trial is testingChidamide With R-CHOP Regimen for DLBCL PatientsWho this might be right forDiffuse Large B Cell Lymphoma First Affiliated Hospital of Zhejiang University 39
Post-approval studies (Phase 4)UnknownNCT02752815What this trial is testingReduced Chemotherapy in Low Risk DLBCLWho this might be right forDiffuse Large B-cell Lymphoma Ruijin Hospital 290
Large-scale testing (Phase 3)Study completedNCT01321541What this trial is testingComparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell TransplantWho this might be right forDiffuse Large B-cell Lymphomade Novo DLBCLDLBCL Transformed From Indolent Lymphoma+1 more CTI BioPharma 312
Testing effectiveness (Phase 2)Study completedNCT01325701What this trial is testingSafety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large Cell B-lymphoma Pharmacyclics LLC. 78